Sylvie Bay

USPTO Granted Patents = 14 (Patent Applications = 3)

CIPO Patents = 2

EPO Patents = 7 (Patent Applications = 12)

Average Co-Inventor Count = 4.9

ph-index = 3

Forward Citations = 23(Granted Patents)

Company Filing History:

Centre National De La Recherche Scientifique

patents

5 out of 168

F. Hoffmann-la Roche Ag

patents

4. 5 out of 4,872

Commissariat À L'Énergie Atomique Et Aux Énergies Alternatives

patents

5. 3 out of 1,744

Institut National De La Sante Et De La Recherche Medicale

patents

6. 3 out of 1,195

United States of America, As Represented by the Secretary of Agriculture

patents

7. 2 out of 41

Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement

patents

8. 1 out of 223

Institut National De La Recherche Agronomique

patents

9. 1 out of 61

Institut National De La Recherche Agronomique (inra)

Universite Paris 13 - Paris Nord

patents

12. 1 out of 319

Assistance Publique-hopitaux De Paris

patents

13. 1 out of 832,891

Other

patents

where one patent can have more than one assignee

Years Active: 2004-2025

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12448412 - Antigenic tripeptides derived fromsubsp.S-type strains, derivatives and uses thereof (2025-10-21),

2. 11981750 - Antigenic tripeptides derived fromsubsp.s-type strains, derivatives and uses thereof (2024-05-14),

3. 11498942 - Antigenic tripeptides derived fromsubsp.s-type strains, derivatives and uses thereof (2022-11-15),

4. 11124563 - Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof (2021-09-21),

5. 11098124 - CD31as a molecular target for imaging of inflammation (2021-08-24),

6. 10899799 - Method for preparing multiple antigen glycopeptide carbohydrate conjugates (2021-01-26),

7. 10787505 - Oligopeptide and methods for producing conjugates thereof (2020-09-29),

8. 10538582 - Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof (2020-01-21),

9. 10087245 - Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof (2018-10-02),

10. 9738712 - Camelid single-domain antibody directed against amyloid beta and methods for producing conjugates thereof (2017-08-22),

11. 9657074 - Enzymatic large-scale synthesis of mucin glyconjugates, and immunogenic applications thereof (2017-05-23),

12. 8883173 - [object Object] (2014-11-11),

13. 7696326 - Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof (2010-04-13),

14. 6676946 - Multiple antigen glycopeptide carbohydrate vaccine comprising the same and use thereof (2004-01-13),

Title: Inventor Sylvie Bay - Revolutionizing Technology in Paris

Introduction: Sylvie Bay is a pioneering inventor based in Paris, France, known for her groundbreaking contributions to the field of technology.

Latest Patents: Sylvie Bay holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing her diverse range of innovative ideas.

Career Highlights: With a career spanning over two decades, Sylvie Bay has worked with leading research institutions and tech companies, consistently pushing the boundaries of technological advancements.

Collaborations: Throughout her career, Sylvie Bay has collaborated with top universities and multinational corporations, fostering a culture of innovation and knowledge-sharing in the tech industry.

Conclusion: Inventor Sylvie Bay's relentless pursuit of innovation and her passion for creating a positive impact through technology make her a true trailblazer in the field of inventions.

This text is generated by artificial intelligence and may not be accurate.